Manufacturers are deeply involved in the development of new pomegranate‐based products, which have acquired great prestige due to many studies proving their potential health benefits. Commercial pomegranate products including capsules and supplements and juices and nectars were assayed. The contents of the key phytochemical compounds (punicalagin, ellagic acid, and total polyphenolic content) and the associated antioxidant capacity (DPPH•, ABTS•+, and FRAP) were analyzed. The experimental ranges of punicalagin and ellagic acid contents were 0.96 to 308 mg/g and 0.09 to 13.1 mg/g, respectively. Punicalagin content was positively correlated (P < 0.001) with DPPH•and total polyphenolic content values. No significant (P> 0.05) correlation was observed among ellagic acid with the antioxidant capacity. The labeling standardization of these products is necessary due to the wide variability among “theoretically” similar pomegranate‐based products. There is a need for labeling “standardization” of these products due to the wide variability of the key compounds (punicalagins, ellagic acid, and the total polyphenolic compounds) among “theoretically” similar pomegranate‐based products. The contents of the key compounds should be declared on product labels, as indicators of the potential health benefits, and should replace subjective functional descriptions.
© 2001-2024 Fundación Dialnet · Todos los derechos reservados